Pancreatic cancer Trials in Nashville, United States
Conditions / Pancreatic cancer / Nashville, United States
Pancreatic cancer is a medical condition with active clinical research programs worldwide.
100 total trials for this combination
Showing top 10 of 100 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05259696 | Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) | COMPLETED | PHASE1/PHASE2 |
| NCT04660929 | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT06440005 | A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT06239194 | Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors | RECRUITING | PHASE1/PHASE2 |
| NCT05708950 | A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) | UNKNOWN | PHASE1/PHASE2 |
| NCT02628535 | Safety Study of MGD009 in B7-H3-expressing Tumors | TERMINATED | PHASE1 |
| NCT04383210 | Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors | TERMINATED | PHASE2 |
| NCT05252390 | NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors | TERMINATED | PHASE1 |
| NCT05366881 | cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease | RECRUITING | — |
| NCT06695845 | A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors | RECRUITING | PHASE2 |